Biliary stent survey
This article was originally published in The Gray Sheet
Executive Summary
Polled interventional radiologists said they would increase their use of biliary stents if the devices received FDA approval for use in the peripheral vasculature, some by as much as 50%, according to a recent survey by the Millennium Research Group. Biliary stents are approved for use in bile ducts only, but are commonly used off label in peripheral arteries. "Physician attitudes toward off-label use of stents may provoke new manufacturer initiatives to obtain artery-specific FDA approval," says Millennium Research Group analyst Darren Navarro. "It might enable manufacturers to increase the price of their stents, growing revenues." The Department of Justice is conducting a civil investigation of allegations that Boston Scientific and other firms promoted biliary stents for off-label uses, Boston Scientific announced Feb. 28 in its annual report
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.